Please provide your email address to receive an email when new articles are posted on . High hematocrit levels were observed among 8.4% of adults receiving gender-confirming testosterone therapy.

Credit: Thinkstock. The risk of hematocrit elevation may depend on testosterone therapy's route of administration, according to investigators. A rise in hematocrit levels occurs with 4 months of ...

The findings suggest the presence of CHIP before HCT may have potential to serve as a biomarker for CVD risk after HCT in patients with multiple myeloma. In patients with multiple myeloma, clonal ...

We know from past research that there is a risk of developing cardiovascular disease (CVD) following an autologous hematopoietic cell transplant (HCT). There are several contributing factors, ...

The EASIX scoring system should not be used to predict outcomes following allogeneic stem cell transplantation (alloSCT) in patients with myelofibrosis. A new study has found that the Hematopoietic ...

Allogeneic hematopoietic-cell transplantation (HCT) in second complete remission achieved 3-year overall survival of 53% and progression-free survival of 46% in adolescents and young adults with acute ...